ANDA簡(jiǎn)化新藥申請(qǐng)abbreviated new drug applications
API原料藥active pharmaceutical ingredient
AQSIQ國(guó)家質(zhì)檢總局Administration of Quality Supervision, Inspection and Quarantine
CBER生物制品評(píng)審與研究中心Center for Biologics Evaluation and Research
CDER藥品審評(píng)與研究中心Center for Drug Evaluation and Research CDER's MAPP 5240.3
CDRH器械和輻射健康中心Center for Devices and Radiological Health
CFDA中國(guó)國(guó)家食品藥品監(jiān)督管理局
cGMP當(dāng)前GMP、國(guó)際GMP規(guī)范 (c=current)
CMC 化學(xué)、制造、控制
DMF藥物主文件drug master file
DUNS Data Universal Numbering System
eCTD電子版通用技術(shù)文件Electronic Common Technical Document
FDASIA Food and Drug Administration Safety and Innovation Act
FDF成品藥、藥品劑型完成 finished dosage form
FEI工廠注冊(cè)識(shí)別號(hào)Facility Establishment Identifier
GDUFA仿制藥企業(yè)付費(fèi)法/仿制藥用戶收費(fèi)法案Generic Drug User Fee Amendment/Act
GMP Good Manufacturing Practice
GPhA美國(guó)仿制藥協(xié)會(huì)@華盛頓
HHS健康和公眾服務(wù)部Health and Human Services
IID非活性成分?jǐn)?shù)據(jù)庫(kù)inactive ingredient database
ICH國(guó)際協(xié)調(diào)會(huì)議International Conference on Harmonisation
IR信息要求information request
NIH美國(guó)國(guó)立衛(wèi)生研究院
OBP生物技術(shù)產(chǎn)品辦公室
OC合規(guī)辦公室Office of Compliance //局長(zhǎng)辦公室/專員Commissioner辦公室
OCC法律事務(wù)辦公室Office of Chief Counsel
OGD仿制藥辦公室Office of Generic Drug
OGROP全球業(yè)務(wù)和政策監(jiān)管辦公室Office of Global Regulatory Operations & Policy
OIP國(guó)際項(xiàng)目辦公室Office of International Programs
OND 新藥辦公室Office of New Drug
ONDQA新藥質(zhì)量評(píng)估辦公室Office of New Drug Quality Assessment
OPQ 藥品質(zhì)量辦公室Office of Pharmaceutical Quality
ORA監(jiān)管事務(wù)辦公室
OSE監(jiān)管和流行病辦公室Office of Surveillance and Epidemiology
OSP戰(zhàn)略項(xiàng)目辦公室
OTS轉(zhuǎn)化科學(xué)辦公室
PAG項(xiàng)目并進(jìn)小組Program Alignment
0571-88272987 88272986 | ||||
杭州翻譯公司,杭州翻譯公司哪個(gè)好,杭州翻譯公司收費(fèi)標(biāo)準(zhǔn) | ||||
浙公網(wǎng)安備 33010802003197號(hào) 浙ICP備15039916號(hào) |
||||